Bluefin Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-605,574
| Closed | -$418K | – | 743 |
|
|
2020
Q4 | $418K | Buy |
+605,574
| New | +$418K | 0.02% | 264 |
|
|
2020
Q3 | – | Sell |
-1,860,353
| Closed | -$6.66M | – | 39 |
|
|
2020
Q2 | $6.66M | Buy |
1,860,353
+349,523
| +23% | +$1.25M | 0.56% | 22 |
|
|
2020
Q1 | $5.74M | Sell |
1,510,830
-600,568
| -28% | -$2.28M | 0.74% | 24 |
|
|
2019
Q4 | $6.36M | Buy |
+2,111,398
| New | +$6.36M | 0.42% | 63 |
|